195 related articles for article (PubMed ID: 17538930)
1. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
3. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
Wang H; Zhang Y; Heuckeroth RO
FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
[TBL] [Abstract][Full Text] [Related]
4. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
6. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
[TBL] [Abstract][Full Text] [Related]
8. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
[TBL] [Abstract][Full Text] [Related]
9. Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.
Gonzalez J; Klein J; Chauhan SD; Neau E; Calise D; Nevoit C; Chaaya R; Miravete M; Delage C; Bascands JL; Schanstra JP; Buffin-Meyer B
Exp Biol Med (Maywood); 2009 Dec; 234(12):1511-8. PubMed ID: 19934371
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator deficiency delays bone repair: roles of osteoblastic proliferation and vascular endothelial growth factor.
Kawao N; Tamura Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E278-88. PubMed ID: 24918201
[TBL] [Abstract][Full Text] [Related]
11. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction.
Liu Z; Sakamoto T; Yokomuro S; Ezure T; Subbotin V; Murase N; Contrucci S; Demetris AJ
Liver; 2000 Apr; 20(2):114-24. PubMed ID: 10847479
[TBL] [Abstract][Full Text] [Related]
12. Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation.
Gujral JS; Liu J; Farhood A; Jaeschke H
Hepatology; 2004 Oct; 40(4):998-1007. PubMed ID: 15382126
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
15. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
[TBL] [Abstract][Full Text] [Related]
16. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
17. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
Osawa Y; Seki E; Adachi M; Suetsugu A; Ito H; Moriwaki H; Seishima M; Nagaki M
Hepatology; 2010 Jan; 51(1):237-45. PubMed ID: 19821528
[TBL] [Abstract][Full Text] [Related]
18. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
[TBL] [Abstract][Full Text] [Related]
19. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
